EGFR and prostate cancer: The miR-125b pathway has been found to be associated with cancers, such as bladder cancer, melanoma, prostate cancer, pancreatic cancer, and colorectal cancer, and several pathways, including the ErbB signaling pathway, the VEGF signaling pathway, and the p53 signaling pathway.